In patients with renal cell carcinoma, IFIT5 expression is significantly higher in primary tumor tissue compared to benign tissues, and elevated levels of IFIT5 mRNA is a predictor of poor overall survival in patients [99]. This evidence concerns the gene IFIT5 and hereditary clear cell renal cell carcinoma.